Turn Therapeutics Inc. ( TTRX) - Key Metrics
TTRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.20 | -$0.03 | -$0.03 |
| 2026Q1 | $0 | -$0.03 | -$0.06 | -$0.06 |
| 2025Q4 | $0 | $0.01 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.07 | -$0.02 | -$0.02 |
| 2025Q2 | $0 | -$0.09 | -$0.04 | -$0.04 |
TTRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.13 |
| 2026Q1 | 0% | -24.32 |
| 2025Q4 | 0% | 103.68 |
| 2025Q3 | 0% | -25.74 |
| 2025Q2 | 0% | -19.38 |
TTRX
Price: $9.90
52 week price:
Earnings Per Share: -0.28 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 285.1 million